WPI 3 (Paliperidone Extended-Release 3 mg)
Pill with imprint WPI 3 is White, Round and has been identified as Paliperidone Extended-Release 3 mg. It is supplied by Actavis Pharma, Inc.
Paliperidone is used in the treatment of schizoaffective disorder; schizophrenia and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Paliperidone 3 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 3
Paliperidone Extended-Release
- Imprint
- WPI 3
- Strength
- 3 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Atypical antipsychotics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis Pharma, Inc.
- National Drug Code (NDC)
- 00591-3693
- Inactive Ingredients
-
ammonia,
butylated hydroxytoluene,
cellulose acetate,
silicon dioxide,
FD&C Red No. 40,
aluminum oxide,
hydroxypropyl cellulose,
hypromelloses,
ferrosoferric oxide,
polyethylene glycol,
povidone,
propylene glycol,
sodium chloride,
stearic acid,
titanium dioxide,
lactose monohydrate,
triacetin
Note: Inactive ingredients may vary.
Related images for "WPI 3"
More about paliperidone
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (496)
- Drug images
- Pricing & coupons
- Drug class: atypical antipsychotics
Patient resources
- Drug Information
- Paliperidone injection
- Paliperidone (Advanced Reading)
- Paliperidone Intramuscular (Advanced Reading)
- Paliperidone Extended-Release Tablets
Other brands
Invega, Invega Sustenna, Invega Trinza, Invega Hafyera
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.